Novartis AGBasel, Switzerland (NYSE: NVS)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Novartis Financial Statements

Novartis Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Novartis Income Statement

  2007 2006 2005
Revenue ($ mil.) 38,947.0 36,749.0 32,526.0
Gross Profit ($ mil.) 27,915.0 26,450.0 23,658.0
Operating Income ($ mil.) 8,226.0 7,944.0 5,515.0
Total Net Income ($ mil.) 11,968.0 5,264.0 5,190.0
Diluted EPS (Net Income) 5.13 2.23 2.62
More Novartis financial information

Novartis Stock Quote & Chart

08/21/08 15:03:23 EST • NYSE • 55.75 • Increased by +0.6600 • Increased by +1.1980 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Novartis Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 3.61 3.75 1.56
Price/Earnings Ratio 11.04 16.34 15.82
Price/Book Ratio 2.85 2.92 1.52
Price/Cash Flow Ratio 15.43 13.17 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Novartis Financial Ratios

Novartis Competitive Intelligence

Johnson & Johnson Merck Pfizer
Annual Sales ($ mil.) 61,095.0 24,197.7 48,418.0
Employees -- 59,800 86,600
Market Cap ($ mil.) 199,077.4 77,000.5 133,815.6

Competitive Landscape